酒精使用障碍中痛敏肽受体的正电子发射断层成像研究
本研究采用[11C]NOP-1A PET测量15例DSM-IV酒精依赖者(戒酒2周)与15名匹配健康对照的NOP受体体内结合,发现酒精依赖组各感兴趣区分布容积与对照组无显著差异,且与临床指标无显著相关。结论不支持酒精依赖者NOP受体结合发生改变,但不能排除痛敏肽传递的变化。
要点
- 酒精依赖者戒酒2周后NOP受体结合与健康对照无显著差异
- NOP受体分布容积与酒精滥用时长、严重度、渴求及焦虑抑郁症状无显著相关
- NOP受体结合无改变不能排除痛敏肽传递异常
核心结论
- 本研究结果不支持酒精依赖者NOP受体结合发生改变,但不能排除痛敏肽传递的变化。
研究设计与样本
- 采用[11C]NOP-1A PET测量15例DSM-IV酒精依赖者与15名年龄、性别、吸烟状态匹配健康对照的NOP受体体内结合。
- 酒精依赖者无共病精神、躯体或药物滥用障碍,经2周门诊监控戒酒(每周3次尿酒精代谢物检测确认)。
- 以动脉输入函数 kinetic 分析测量感兴趣区(包括杏仁核、海马、中脑、纹状体及前额皮质亚区)的[11C]NOP-1A分布容积。
主要发现
- 酒精依赖组各感兴趣区[11C]NOP-1A分布容积与健康对照无显著差异。
- 经多重假设校正后,[11C]NOP-1A分布容积与酒精滥用时长、严重度、渴求及焦虑或抑郁症状等临床指标均无显著关系。
临床怎么用
- 本研究不支持以NOP受体结合改变作为酒精依赖的体内影像标志物。
- 靶向痛敏肽受体的药物研发不宜仅基于受体结合变化假设,需进一步评估痛敏肽传递功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The neuropeptide transmitter nociceptin, which binds to the nociceptin/orphanin FQ peptide (NOP) receptor, is a core component of the brain's antistress system. Nociceptin exerts its antistress effect by counteracting the functions of corticotropin-releasing factor, the primary stress-mediating neuropeptide in the brain. Basic investigations support a role for medications that target nociceptin receptors in the treatment of alcohol use disorders. Thus, it is of high interest to measure the in vivo status of NOP receptors in individuals with alcohol use disorders. METHODS: Here, we used [11C]NOP-1A and positron emission tomography to measure the in vivo binding to NOP receptors in 15 alcohol-dependent humans as identified by DSM-IV and 15 healthy control subjects matched for age, sex, and smoking status. Alcohol-dependent individuals with no comorbid psychiatric, medical, or drug abuse disorders were scanned following 2 weeks of outpatient monitored abstinence (confirmed with three times per week urine alcohol metabolite testing). [11C]NOP-1A distribution volume in regions of interest (including the amygdala, hippocampus, and midbrain, striatal, and prefrontal cortical subdivisions) was measured with kinetic analysis using the arterial input function. RESULTS: Regional [11C]NOP-1A distribution volume in alcohol dependence was not significantly different compared with healthy control subjects. No relationship between [11C]NOP-1A distribution volume and other clinical measures (including duration and severity of alcohol abuse, craving, and anxiety or depressive symptoms) were significant after correction for the multiple hypotheses tested. CONCLUSIONS: The results of this study do not support alterations in the binding to NOP receptors in alcohol dependence. However, this finding does not necessarily rule out alterations in nociceptin transmission in alcohol dependence.
引用
- Narendran R, Ciccocioppo R, Lopresti B, et al. Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [11C]NOP-1A. Biol Psychiatry. 2017. PMID: 28711193. doi:10.1016/j.biopsych.2017.05.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。